Similar articles for PMID: 22258169

Year	Number of Results
1993	1
2000	2
2001	1
2002	1
2005	4
2006	13
2007	11
2008	4
2009	9
2010	15
2011	28
2012	38
2013	42
2014	40
2015	33
2016	26
2017	21
2018	7
2019	6
2020	4
2021	8
2022	2
2023	1
2024	0

1

Natalizumab-associated progressive multifocal leucoencephalopathy: a practical approach to risk profiling and monitoring.

Hunt D, Giovannoni G. Hunt D, et al. Pract Neurol. 2012 Feb;12(1):25-35. doi: 10.1136/practneurol-2011-000092. Pract Neurol. 2012. PMID: 22258169 Review.

2

Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab.

Sørensen PS, Bertolotto A, Edan G, Giovannoni G, Gold R, Havrdova E, Kappos L, Kieseier BC, Montalban X, Olsson T. Sørensen PS, et al. Mult Scler. 2012 Feb;18(2):143-52. doi: 10.1177/1352458511435105. Mult Scler. 2012. PMID: 22312009 Review.

3

Risk of natalizumab-associated progressive multifocal leukoencephalopathy.

Bloomgren G, Richman S, Hotermans C, Subramanyam M, Goelz S, Natarajan A, Lee S, Plavina T, Scanlon JV, Sandrock A, Bozic C. Bloomgren G, et al. N Engl J Med. 2012 May 17;366(20):1870-80. doi: 10.1056/NEJMoa1107829. N Engl J Med. 2012. PMID: 22591293 Free article.

4

A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.

Lee P, Plavina T, Castro A, Berman M, Jaiswal D, Rivas S, Schlain B, Subramanyam M. Lee P, et al. J Clin Virol. 2013 Jun;57(2):141-6. doi: 10.1016/j.jcv.2013.02.002. Epub 2013 Mar 5. J Clin Virol. 2013. PMID: 23465394

5

The link between VLA-4 and JC virus reactivation.

Monaco MC, Major EO. Monaco MC, et al. Expert Rev Clin Immunol. 2012 Jan;8(1):63-72. doi: 10.1586/eci.11.85. Expert Rev Clin Immunol. 2012. PMID: 22149341 Review.

6

Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.

Trampe AK, Hemmelmann C, Stroet A, Haghikia A, Hellwig K, Wiendl H, Goelz S, Ziegler A, Gold R, Chan A. Trampe AK, et al. Neurology. 2012 May 29;78(22):1736-42. doi: 10.1212/WNL.0b013e3182583022. Epub 2012 May 16. Neurology. 2012. PMID: 22592369

7

Progressive multifocal leukoencephalopathy in patients with multiple sclerosis.

Baldwin KJ, Hogg JP. Baldwin KJ, et al. Curr Opin Neurol. 2013 Jun;26(3):318-23. doi: 10.1097/WCO.0b013e328360279f. Curr Opin Neurol. 2013. PMID: 23493158 Review.

8

Lessons learned from fatal progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumab.

Boster AL, Nicholas JA, Topalli I, Kisanuki YY, Pei W, Morgan-Followell B, Kirsch CF, Racke MK, Pitt D. Boster AL, et al. JAMA Neurol. 2013 Mar 1;70(3):398-402. doi: 10.1001/jamaneurol.2013.1960. JAMA Neurol. 2013. PMID: 23338729 Review.

9

Review of progressive multifocal leukoencephalopathy and natalizumab.

Aksamit AJ. Aksamit AJ. Neurologist. 2006 Nov;12(6):293-8. doi: 10.1097/01.nrl.0000250948.04681.96. Neurologist. 2006. PMID: 17122725 Review.

10

Advances in the management of PML: focus on natalizumab.

Fox R. Fox R. Cleve Clin J Med. 2011 Nov;78 Suppl 2:S33-7. doi: 10.3949/ccjm.78.s2.08. Cleve Clin J Med. 2011. PMID: 22123933 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

276 results

Results by year